Desmopressin in moderate hemophilia A patients: a treatment worth considering

Desmopressin increases endogenous factor VIII levels in hemophilia A. Large inter-individual variation in the response to desmopressin is observed. Patients with a lower baseline factor VIII activity tend to show a reduced response, therefore, desmopressin is less frequently used in moderate hemophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Loomans, Janneke I., Kruip, Marieke J.H.A., Carcao, Manuel, Jackson, Shannon, van Velzen, Alice S., Peters, Marjolein, Santagostino, Elena, Platokouki, Helen, Beckers, Erik, Voorberg, Jan, van der Bom, Johanna G., Fijnvandraat, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830393/
https://www.ncbi.nlm.nih.gov/pubmed/29305412
http://dx.doi.org/10.3324/haematol.2017.180059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830393/
https://www.ncbi.nlm.nih.gov/pubmed/29305412
http://dx.doi.org/10.3324/haematol.2017.180059

Ejemplares similares